This study aimed to evaluate MR as an imaging modality for the assessment of myometrial and cervical invasion in endometrial carcinoma and for the assessment of parametrial and lymph node involvement in cervical carcinoma.
INTRODUCTION
Endometrial and cervical carcinoma represent the first and third most common cancers of the female genital tract in UK. In endometrial carcinoma (Table I) . We understaged two patients with endometrial carcinoma, one of whom had coexistent leiomyomata. The second patient had tumour in the fallopian tube, which was not picked up on MR (Table 1) . One patient with leiomyomata was overstaged as having stage 2A. Histology revealed that the tumour extended into the isthmus but not into the cervical canal.
Our accuracy in assessing myometrial and cervical involvement in patients with endometrial carcinoma was 78% for both (Table II) .
Cervical carcinoma:
We understaged one patient in whom the tumour had just breached into the parametrium. One of the patients was overstaged as stage 2A whereas histology revealed the tumour to be restricted to the cervix (Table III) . Our accuracy in assessing parametrial and lymph node involvement in patients with cervical carcinoma was 71% and 86% respectively (Table IV) . Deep myometrial invasion to the outer half of the myometrium (FIGO stage IC) is a poor prognostic factor, which is associated with an increased risk of pelvic, and para-aortic lymph node metastases.4 MR permits accurate assessment of myometrial involvement preoperatively. This is useful in selecting patients who require pelvic lymphadenectomy and hence referral to specialised centralised gynaecological oncology centres.5 Large polypoidal tumours, leiomyomata, adenomyosis, congenital anomalies, small uteri, indistinct zonal anatomy and other factors may make it difficult to assess myometrial invasion at MR imaging.6 Two of our patients who were inaccurately staged had coexistent leiomyomata. The use of the whole body coil and the coexistent pathology in two ofour patients may have affected our accuracy in assessing myometrial invasion. The accuracy rates for estimating extent of myometrial invasion in the literature are 74%-8%78 Our accuracy in predicting myometrial invasion was 78% (Table II) . Cervical involvement is seen in approximately 10% -15% of endometrial carcinoma.9 The presence of cervical stromal invasion would be an indication for radical hysterectomy.'0 MR, although relatively insensitive in diagnosing superficial cervical involvement, is accurate in detecting cervical stromal invasion."l Some would argue that superficial cervical involvement is not a prognostic factor.'2 In our series the accuracy in assessing cervical invasion was 78%o, which compares favourably with studies from the literature. " I Cervical carcinoma
Radical surgery for cervical cancer confined to the cervix (stage 1) shows a 5-year survival rate of up to 90%. Surgical cure can be realistically achieved if tumour free excision margins are at least one centimetre and there is no lymph node involvement. Surgical treatment for tumours stage 2A or greater involves extensive radical surgery. i.e. pelvic exenteration. Most units in UK would prefer to use radiotherapy or chemoradiation as the first line of management. Traditionally, the staging of this disease has involved examination under anaesthesia, cystoscopy and intravenous urography/ultrasonography (to rule out hydronephrosis). Clinical staging has been shown to be inaccurate and often results in understaging. 3 The overall accuracy of MR in the evaluation of parametrial involvement is 67%-94%.'4 15, 16 Our accuracy in assessing parametrial invasion compares favourably with studies from literature. False negatives can be due to microscopic tumour spread into the parametrium and false positives due to cervical stromal and adjacent parametrial tissue oedema. The presence of lymph node metastases does not change the FIGO staging. However, it affects the adjuvant treatment (patients with positive lymph nodes would require radiotherapy or chemoradiation) and prognosis. Lymph node metastases are present in approximately 18.6% of cervical carcinoma lesser than or equal to stage 2A and in 44.3% greater than stage 2B.17 The reported accuracy rates for lymph node evaluation is 72-90O%. 16, 18 In our series, the accuracy for lymph node assessment was 86%.
In conclusion, MR is a reliable method for determining the depth of myometrial invasion and cervical extension in patients with endometrial carcinoma. Presurgical knowledge ofthese factors helps select patients likely to benefit from pelvic lymphadenectomy and hence to be considered for specialist referral.
